Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MHCD |
---|---|---|
09:32 ET | 1000 | 11.68 |
09:33 ET | 400 | 11.63 |
02:09 ET | 500 | 11.67 |
03:03 ET | 100 | 11.7 |
03:57 ET | 600 | 11.68 |
US Equity | 74.8% |
---|---|
Int'l Equity | 14.9% |
CDN Equity | 8.0% |
Cash | 2.3% |
Fixed Income | 0 |
Other | 0 |
Healthcare | 85.1% |
---|---|
Real Estate | 7.6% |
Basic Mat. | 0 |
Communication Services | 0 |
Consumer Cyclical | 0 |
Consumer Defensive | 0 |
Energy | 0 |
Financial Serv.s | 0 |
Industrials | 0 |
Technology | 0 |
Utilities | 0 |
United States | 76.5% |
---|---|
Canada | 8.2% |
Europe | 3.0% |
Africa | 0 |
Latin America | 0 |
Asia/Oceania | 0 |
Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
---|---|---|---|---|
Eli Lilly and Co | Long | 6.9% | 0.00% | $11.1M |
UnitedHealth Group Inc | Long | 5.6% | -1.72% | $9.0M |
Chartwell Retirement Residences | Long | 5.4% | 0.00% | $8.6M |
AstraZeneca PLC | Long | 5.1% | 0.00% | $8.1M |
AbbVie Inc | Long | 5.1% | -10.94% | $8.1M |
Boston Scientific Corp | Long | 4.5% | -6.06% | $7.3M |
Merck & Co Inc | Long | 4.5% | 0.00% | $7.1M |
Johnson & Johnson | Long | 4.3% | 0.00% | $6.9M |
Thermo Fisher Scientific Inc | Long | 4.0% | 0.00% | $6.5M |
Stryker Corp | Long | 4.0% | 0.00% | $6.5M |
Time Horizon | Star Rating |
---|---|
Overall Rating | Not Rated |
3 Year Rating | Not Rated |
5 Year Rating | Not Rated |
10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
---|---|
Category | Sector Equity |
Sponsor | Middlefield Limited |
Inception | July 21, 2017 |
The investment objectives of the fund are to provide holders of Healthcare Units with: (a) stable monthly cash distributions; and (b) enhanced long-term total return through capital appreciation of the Healthcare investment portfolio through an investment strategy that focuses primarily on investing in dividend-paying securities of issuers operating in, or that derive a significant portion of their revenue or earnings from, products or services related to the healthcare, life sciences and related industries.
Total Net Assets | $159.9M |
---|---|
Shares Out. | 13.8M |
Net Asset Value (NAV) | $11.65 |
Prem/Discount to NAV | -0.01% |
P/E Ratio | 36.2 |
Dividend Yield | 5.57% |
Dividend per Share | 0.65 CAD |
Ex-Dividend Date | 11/29/2024 |
Dividend Payment Date | 12/13/2024 |
Beta | --- |
Morningstar Investment Style | Sector Equity |
Equity Style | Large Cap Blend |
Credit Quality / Duration | --- |
Actual Management Fee | 0.85% |
---|---|
Actual Mgmt. Expense Ratio (MER) | 1.34% |